Form CORRESP - Correspondence:
SEC Accession No. 0001104659-25-076067
Filing Date
2025-08-11
Accepted
2025-08-11 12:00:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4961
  Complete submission text file 0001104659-25-076067.txt   6014
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Liminatus Pharma, Inc. (Filer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)